Grants & Programs

CVC Trials Network

Established in 2001 through a partnership between the Cancer Research Institute and Ludwig Cancer Research, the CVC Trials Network is a coordinated global research team composed of more than 60 of the world's top clinical immunologists.

The Network meets in person twice yearly, collaborates year-round on clinical trials, and regularly shares new findings, questions, and ideas for trials.

The CVC Trials Network is distinguished by a centrally coordinated approach and field-leading expertise in immunological monitoring and immunotherapy trial design.
 

Global Membership

United States

  • James P. Allison, Ph.D., The University of Texas MD Anderson Cancer Center
  • Nina Bhardwaj, M.D., Ph.D., Mount Sinai School of Medicine
  • Timothy A. Chan, M.D., Ph.D., Memorial Sloan Kettering Cancer Center
  • Hearn Jay Cho, M.D., Ph.D., Mount Sinai School of Medicine
  • Glenn Dranoff, M.D., Dana-Farber Cancer Institute, Harvard Medical School
  • Gavin Dunn, M.D., Ph.D., Washington University in Saint Louis
  • Lawrence Fong, M.D., University of California, San Francisco
  • Leena Gandhi, M.D., Ph.D., Dana-Farber Cancer Institute
  • Sacha Gnjatic, Ph.D., Mount Sinai School of Medicine
  • Philip D. Greenberg, M.D., Fred Hutchinson Cancer Research Center, University of Washington
  • F. Stephen Hodi Jr., M.D., Dana-Farber Cancer Institute, Harvard Medical School
  • Elizabeth M. Jaffee, M.D., Johns Hopkins University School of Medicine
  • Carl H. June, M.D., Perelman School of Medicine, University of Pennsylvania
  • Achim Jungbluth, M.D., Memorial Sloan Kettering Cancer Center
  • Thomas J. Kaley, M.D., Memorial Sloan Kettering Cancer Center
  • John M. Kirkwood, M.D., University of Pittsburgh Medical Center
  • Alexander M. Lesokhin, M.D., Memorial Sloan Kettering Cancer Center
  • Kunle Odunsi, M.D., Ph.D., Roswell Park Cancer Institute
  • Hideho Okada, M.D., Ph.D., University of California, San Francisco
  • Drew M. Pardoll, M.D., Ph.D., Johns Hopkins University School of Medicine
  • Marshall R. Posner, M.D., Mount Sinai School of Medicine
  • David Reardon, M.D., Dana-Farber Cancer Institute, Harvard Medical School
  • Antoni Ribas, M.D., Ph.D., University of California, Los Angeles
  • Michel Sadelain, M.D., Ph.D., Memorial Sloan Kettering Cancer Center
  • Yvonne Saenger, M.D., Mount Sinai School of Medicine
  • Neil H. Segal, M.D., Ph.D., Memorial Sloan Kettering Cancer Center
  • Padmanee Sharma, M.D., Ph.D., The University of Texas MD Anderson Cancer Center
  • Andrew G. Sikora, M.D., Baylor College of Medicine
  • Craig L. Slingluff Jr., M.D., University of Virginia Health System
  • Mario Sznol, M.D., Yale Cancer Center
  • Suzanne L. Topalian, M.D., Johns Hopkins University School of Medicine
  • Ralph R. Weichselbaum, M.D., University of Chicago
  • Jedd D. Wolchok, M.D., Ph.D., (chair) Memorial Sloan Kettering Cancer Center, Ludwig Cancer Research
  • Cassian Yee, M.D., The University of Texas MD Anderson Cancer Center
  • Hassane M. Zarour, M.D., University of Pittsburgh Medical Center

Europe

  • Maha Ayyoub, Ph.D., Centre de Lutte Contre Le Cancer Nantes-Atlantique, France
  • Luigi Buonaguro, M.D., National Cancer Institute Pascale, Naples, Italy
  • Vincenzo Cerundolo, M.D., Ph.D., University of Oxford, Oxford, United Kingdom
  • George Coukos, M.D., Ph.D., University Hospital of Lausanne (CHUV), Switzerland
  • Dirk Jaeger, M.D., National Center for Tumor Diseases, University Clinic of Heidelberg, Germany
  • Elke Jaeger, M.D., Krankenhaus Nordwest, Frankfurt, Germany
  • Judith Kroep, M.D., Ph.D., Leiden University Medical Center, The Netherlands
  • Simon A. Laban, M.D., University of Ulm, Germany
  • Cornelis (Kees) J.M. Melief, M.D., Ph.D., Leiden University Medical Center, The Netherlands
  • Pedro J. Romero, M.D., Universite de Lausanne, Switzerland
  • Daniel E. Speiser, M.D., Universite de Lausanne, Switzerland
  • Danila Valmori, Ph.D., Centre de Lutte Contre Le Cancer Nantes-Atlantique, France
  • Nicolas Van Baren, M.D., Ph.D., Ludwig Institute for Cancer Research, Brussels, Belgium
  • Maries van den Broek, Ph.D., University of Zurich, Switzerland
  • Benoit J. Van den Eynde, M.D., Ph.D., Ludwig Institute for Cancer Research, Brussels, Belgium
  • Pierre van der Bruggen, Ph.D., Ludwig Institute for Cancer Research, Brussels, Belgium
  • Sjoerd Henricus van der Burg, Ph.D., Leiden University Medical Center, The Netherlands
  • Alfred Zippelius, M.D., University of Basel, Switzerland

Asia

  • Shinichi Kageyama, M.D., Mie University School of Medicine, Japan
  • Alexander Knuth, M.D., National Center for Cancer Care & Research, Qatar
  • Eiichi Nakayama, M.D., Ph.D., Kawasaki University of Medical Welfare, Japan
  • Hiroyoshi Nishikawa, M.D., Ph.D., Osaka University, Japan
  • Hiroshi Shiku, M.D., Mie University School of Medicine, Japan
  • Hisashi Wada, M.D., Ph.D., Osaka University, Japan

Australia

  • Jonathan S. Cebon, MB BS, Ph.D., FRACP, Austin Health, Ludwig Cancer Research
  • Mark J. Smyth, Ph.D., QIMR Berghofer Medical Research Institute